|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 25, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales (exclusive of depreciation and amortization shown separately below) | |||||
| Selling, General and Administrative Expense | |||||
| Depreciation | |||||
| Amortization | |||||
| Management fees to related party | |||||
| Other (income) expense, net | |||||
| Income from operations | |||||
| Fair Value Adjustment of Warrants | |||||
| Interest expense, net | |||||
| Interest expense on junior subordinated debentures | |||||
| Investment income on trust common securities | |||||
| Income on mark-to-market adjustment of interest rate swap | |||||
| Refinancing costs | |||||
| Income (loss) before income taxes | |||||
| Income tax expense | |||||
| Net income (loss) | |||||
| Other comprehensive income (loss): | |||||
| Foreign currency translation adjustments | |||||
| Hedging activity | |||||
| Total other comprehensive income (loss) | |||||
| Comprehensive income (loss) | |||||
| Basic income (loss) per share | |||||
| Weighted average basic shares outstanding | |||||
| Earnings Per Share, Diluted | |||||
| Weighted Average Number of Shares Outstanding, Diluted |
Loading...
